Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Baxter
Mallinckrodt
Colorcon
Medtronic

Last Updated: May 28, 2022

DETROL LA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Detrol La, and what generic alternatives are available?

Detrol La is a drug marketed by Upjohn and is included in one NDA.

The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.

Drug patent expirations by year for DETROL LA
Drug Prices for DETROL LA

See drug prices for DETROL LA

Drug Sales Revenue Trends for DETROL LA

See drug sales revenues for DETROL LA

Recent Clinical Trials for DETROL LA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San FranciscoPhase 4
Astellas Scientific & Medical Affairs, Inc.
Astellas Pharma Global Development, Inc.Phase 4

See all DETROL LA clinical trials

Pharmacology for DETROL LA
Paragraph IV (Patent) Challenges for DETROL LA
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
DETROL LA Extended-release Capsules tolterodine tartrate 2 mg and 4 mg 021228 1 2007-07-30

US Patents and Regulatory Information for DETROL LA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 AB RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DETROL LA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 See Plans and Pricing See Plans and Pricing
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 See Plans and Pricing See Plans and Pricing
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 See Plans and Pricing See Plans and Pricing
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 See Plans and Pricing See Plans and Pricing
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 See Plans and Pricing See Plans and Pricing
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 See Plans and Pricing See Plans and Pricing
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for DETROL LA

See the table below for patents covering DETROL LA around the world.

Country Patent Number Title Estimated Expiration
Canada 2350061 NOUVEAU COMPRIME A LIBERATION CONTROLEE, METHODE DE PRODUCTION, ET FORMULATION MULTICOUCHE COMPRENANT LEDIT COMPRIME (NEW CONTROLLED RELEASE BEAD, A METHOD OF PRODUCING THE SAME AND MULTIPLE UNIT FORMULATION COMPRISING IT) See Plans and Pricing
Slovakia 284758 See Plans and Pricing
Czech Republic 304671 Farmaceutický prostředek obsahující tolterodin a jeho použití (Pharmaceutical preparation containing tolterodine and use thereof) See Plans and Pricing
Serbia 49891 NOVE PERLE SA KONTROLISANIM OSLOBADJANJEM, POSTUPAK ZA NJIHOVU PROIZVODNJU I VIŠESTRUKA JEDINIČNA FORMULACIJA KOJA IH SADRŽI (NEW CONTROLLED RELEASE BEAD, A METHOD OF PRODUCING THE SAME AND MULTIPLE UNIT FORMULATION COMPRlSING IT) See Plans and Pricing
World Intellectual Property Organization (WIPO) 0012070 See Plans and Pricing
Norway 329830 See Plans and Pricing
Eurasian Patent Organization 200000468 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for DETROL LA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0325571 1998C0031 Belgium See Plans and Pricing PRODUCT NAME: TOLTERODINI-L-TARTRAS (=TOLTERODINUM); NATL REGISTRATION NO/DATE: 277 IS 301 F 3 19980309; FIRST REGISTRATION: SE 13475 19970905
0325571 21/1998 Austria See Plans and Pricing PRODUCT NAME: TOLTERODIN, SEINE SALZE, RACEMATE UND ENANTIOMERE; NAT. REGISTRATION NO/DATE: 1-22389 UND 1-22390 19980210; FIRST REGISTRATION: SE 13475 UND 13476 19970905
0325571 C980020 Netherlands See Plans and Pricing PRODUCT NAME: TOLTERODINE, DESGEWENST IN DE VORM VAN EEN ZOUT MET EEN FYSIOLO GISCH ACCEPTABEL ZUUR, IN HET BIJZONDER TOLTERODINE L-TARTRAAT; NAT. REGISTRATION NO/DATE: RVG 22148, RVG 22149 19980217; FIRST REGISTRATION: SE 13475, 13476 19970905
0325571 SPC/GB98/027 United Kingdom See Plans and Pricing PRODUCT NAME: TOLTERODINE OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: SE 13475 19970905; SE 13476 19970905; UK 00032/0222 19980203; UK 00032/0223 19980203
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Boehringer Ingelheim
Merck
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.